These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 11278809)
1. Selective roles of retinoic acid receptor and retinoid x receptor in the suppression of apoptosis by all-trans-retinoic acid. Konta T; Xu Q; Furusu A; Nakayama K; Kitamura M J Biol Chem; 2001 Apr; 276(16):12697-701. PubMed ID: 11278809 [TBL] [Abstract][Full Text] [Related]
2. Transcriptional induction of mitogen-activated protein kinase phosphatase 1 by retinoids. Selective roles of nuclear receptors and contribution to the antiapoptotic effect. Xu Q; Konta T; Furusu A; Nakayama K; Lucio-Cazana J; Fine LG; Kitamura M J Biol Chem; 2002 Nov; 277(44):41693-700. PubMed ID: 12186877 [TBL] [Abstract][Full Text] [Related]
3. Interleukin-1 beta-mediated suppression of RXR:RAR transactivation of the Ntcp promoter is JNK-dependent. Li D; Zimmerman TL; Thevananther S; Lee HY; Kurie JM; Karpen SJ J Biol Chem; 2002 Aug; 277(35):31416-22. PubMed ID: 12105223 [TBL] [Abstract][Full Text] [Related]
4. All-trans-retinoic acid inhibits Jun N-terminal kinase-dependent signaling pathways. Lee HY; Walsh GL; Dawson MI; Hong WK; Kurie JM J Biol Chem; 1998 Mar; 273(12):7066-71. PubMed ID: 9507016 [TBL] [Abstract][Full Text] [Related]
5. Suppression of apoptosis by all-trans-retinoic acid. Dual intervention in the c-Jun n-terminal kinase-AP-1 pathway. Moreno-Manzano V; Ishikawa Y; Lucio-Cazana J; Kitamura M J Biol Chem; 1999 Jul; 274(29):20251-8. PubMed ID: 10400643 [TBL] [Abstract][Full Text] [Related]
6. Anti-apoptotic effect of quercetin: intervention in the JNK- and ERK-mediated apoptotic pathways. Ishikawa Y; Kitamura M Kidney Int; 2000 Sep; 58(3):1078-87. PubMed ID: 10972672 [TBL] [Abstract][Full Text] [Related]
7. Increased retinoic acid responsiveness in lung carcinoma cells that are nonresponsive despite the presence of endogenous retinoic acid receptor (RAR) beta by expression of exogenous retinoid receptors retinoid X receptor alpha, RAR alpha, and RAR gamma. Wan H; Hong WK; Lotan R Cancer Res; 2001 Jan; 61(2):556-64. PubMed ID: 11212249 [TBL] [Abstract][Full Text] [Related]
8. Reduction of both RAR and RXR levels is required to maximally alter sensitivity of CA-OV3 ovarian tumor cells to growth suppression by all-trans-retinoic acid. Wu S; Zhang ZP; Zhang D; Soprano DR; Soprano KJ Exp Cell Res; 1997 Nov; 237(1):118-26. PubMed ID: 9417874 [TBL] [Abstract][Full Text] [Related]
9. Synergistic activation of retinoic acid (RA)-responsive genes and induction of embryonal carcinoma cell differentiation by an RA receptor alpha (RAR alpha)-, RAR beta-, or RAR gamma-selective ligand in combination with a retinoid X receptor-specific ligand. Roy B; Taneja R; Chambon P Mol Cell Biol; 1995 Dec; 15(12):6481-7. PubMed ID: 8524212 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of trans-retinoic acid-resistant human breast cancer cell growth by retinoid X receptor-selective retinoids. Wu Q; Dawson MI; Zheng Y; Hobbs PD; Agadir A; Jong L; Li Y; Liu R; Lin B; Zhang XK Mol Cell Biol; 1997 Nov; 17(11):6598-608. PubMed ID: 9343423 [TBL] [Abstract][Full Text] [Related]
11. Mitogen-activated protein kinases and mitogen-activated protein kinase phosphatases mediate the inhibitory effects of all-trans retinoic acid on the hypertrophic growth of cardiomyocytes. Palm-Leis A; Singh US; Herbelin BS; Olsovsky GD; Baker KM; Pan J J Biol Chem; 2004 Dec; 279(52):54905-17. PubMed ID: 15494319 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of both RAR and RXR restores AP-1 repression in ovarian adenocarcinoma cells resistant to retinoic acid-dependent growth inhibition. Soprano DR; Chen LX; Wu S; Donigan AM; Borghaei RC; Soprano KJ Oncogene; 1996 Feb; 12(3):577-84. PubMed ID: 8637715 [TBL] [Abstract][Full Text] [Related]
13. Selective stimulation by ceramide of the expression of the alpha isoform of retinoic acid and retinoid X receptors in osteoblastic cells. A role of sphingosine 1-phosphate-mediated AP-1 in the ligand-dependent transcriptional activity of these receptors. Takeshita A; Watanabe A; Takada Y; Hanazawa S J Biol Chem; 2000 Oct; 275(41):32220-6. PubMed ID: 10915783 [TBL] [Abstract][Full Text] [Related]
14. Intervention by retinoic acid in oxidative stress-induced apoptosis. Kitamura M; Ishikawa Y; Moreno-Manzano V; Xu Q; Konta T; Lucio-Cazana J; Furusu A; Nakayama K Nephrol Dial Transplant; 2002; 17 Suppl 9():84-7. PubMed ID: 12386300 [TBL] [Abstract][Full Text] [Related]
15. Potentiation of VD-induced monocytic leukemia cell differentiation by retinoids involves both RAR and RXR signaling pathways. Defacque H; Sévilla C; Piquemal D; Rochette-Egly C; Marti J; Commes T Leukemia; 1997 Feb; 11(2):221-7. PubMed ID: 9009084 [TBL] [Abstract][Full Text] [Related]
17. Endogenous retinoic acid receptor (RAR)-retinoid X receptor (RXR) heterodimers are the major functional forms regulating retinoid-responsive elements in adult human keratinocytes. Binding of ligands to RAR only is sufficient for RAR-RXR heterodimers to confer ligand-dependent activation of hRAR beta 2/RARE (DR5). Xiao JH; Durand B; Chambon P; Voorhees JJ J Biol Chem; 1995 Feb; 270(7):3001-11. PubMed ID: 7852380 [TBL] [Abstract][Full Text] [Related]
18. Regulation of retinoid-induced differentiation in embryonal carcinoma PCC4.aza1R cells: effects of retinoid-receptor selective ligands. Mills KJ; Vollberg TM; Nervi C; Grippo JF; Dawson MI; Jetten AM Cell Growth Differ; 1996 Mar; 7(3):327-37. PubMed ID: 8838863 [TBL] [Abstract][Full Text] [Related]
19. Retinoic acid receptors and retinoid X receptor-alpha down-regulate the transforming growth factor-beta 1 promoter by antagonizing AP-1 activity. Salbert G; Fanjul A; Piedrafita FJ; Lu XP; Kim SJ; Tran P; Pfahl M Mol Endocrinol; 1993 Oct; 7(10):1347-56. PubMed ID: 8264664 [TBL] [Abstract][Full Text] [Related]
20. Retinoid X receptor agonists modulate Foxp3⁺ regulatory T cell and Th17 cell differentiation with differential dependence on retinoic acid receptor activation. Takeuchi H; Yokota-Nakatsuma A; Ohoka Y; Kagechika H; Kato C; Song SY; Iwata M J Immunol; 2013 Oct; 191(7):3725-33. PubMed ID: 23980207 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]